
- 1 day ago
- 2 min
Clario invests in new technology to reduce translation times for clinical trials

- Aug 5
- 2 min
Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

- Aug 3
- 3 min
IDRx raises $122 million to transform cancer treatment with precision combination therapies

- Jul 29
- 3 min
HempMy Pet and Tarleton University announce positive results of their study using CBD on horses

- Jul 11
- 3 min
FIRST IN HUMAN SUBJECTS ENROLLED IN AQUALUNG THERAPEUTICS PHASE 1A STUDY OF ALT-100

- Jul 9
- 4 min
Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology

- Jun 5
- 3 min
Imaging Endpoints and ImaginAb partner to supply doses of the CD8 imaging agent for clinical trials

- May 14
- 7 min
Mitsubishi Tanabe Pharma America obtains FDA approval of its RADICAVA ORS for the treatment of ALS

- May 7
- 2 min
Sen-Jam Pharmaceutical Enrolls Patients in its COVID Therapy Phase 2 Clinical Trial

- May 4
- 3 min
Four pharma solution providers launch Norstella to provide faster patient access to therapies

- Apr 15
- 4 min
With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test

- Apr 7
- 2 min
ENDOVASCULAR ENGINEERING CLOSES ON $15 MILLION FOR VENOUS THROMBECTOMY SOLUTIONS

- Mar 26
- 3 min
Geneos Therapeutics closes on $17 million to advance its personalized cancer immunotherapy platform

- Mar 24
- 3 min
Sen-Jam Pharmaceutical partners with KVK Tech for Covid oral therapeutic

- Mar 21
- 3 min
Triumvia Immunologics completes $100 million round for its T cell therapeutics

- Mar 2
- 2 min
Alcami, the contract development and manufacturer adds formulation development laboratory

- Feb 28
- 4 min
Algernon Pharmaceuticals starts chronic kidney disease research program

- Feb 19
- 2 min
Dizal Pharmaceutical obtains FDA Fast Track Designation for its drug for Refractory T-Cell Lymphoma

- Feb 14
- 5 min
Otsuka and Sunovlon start Phase 3 trials for a treatment for biopolar depression

- Feb 12
- 4 min
Orthox raises $12.5 million to begin clinical trials for knee cartilage repair